FY2025 · ended Dec 31, 2025 · Revenue $2.72B, +1.0% YoY · Filed Feb 26, 2026
Fortrea Holdings Inc. (FTRE) files with the SEC under industry code 8071, Services-Medical Laboratories. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.7 billion and a net loss of $986.2 million. Free cash flow was $88.3 million. As of Sep 30, 2026 it held $220.6 million in cash and investments and $1.1 billion in total debt.
Revenue (TTM)
$2.67B
-3.4% vs year-ago TTM
Net income (TTM)
$-68.70M
+93.2% vs year-ago TTM
Operating cash flow (TTM)
$201.80M
+13353.3% vs year-ago TTM
Free cash flow (TTM)
$169.00M
+1400.0% vs year-ago TTM
EPS
$-10.81
-194.6% vs prior year
Dividend per share
None
Shares outstanding
93.50M
+3.7% vs prior year
Net cash
$-897.80M
as of Sep 30, 2026
Operating margin
0.5%
FY 2026
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FTRE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Durham, NC
- SEC filer status
- Accelerated filer
- SEC CIK
- 1965040
- Former names
- Silver Spinco Inc. (until Apr 5, 2023)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $2.7B | $2.7B | $2.8B |
| Operating income | -$872.6M | -$161.9M | $32.0M |
| Net income | -$986.2M | -$328.5M | -$25.2M |
| Diluted EPS | -$10.81 | -$3.67 | -$0.29 |
| Operating cash flow | $113.5M | $262.8M | $168.4M |
| Free cash flow | $88.3M | $237.3M | $128.1M |
| Total assets | $2.7B | $3.6B | $4.3B |
| Total liabilities | $2.2B | $2.2B | $2.6B |
| Stockholders' equity | $563.5M | $1.4B | $1.7B |
| Cash and investments | $174.6M | $118.5M | $108.6M |
| Total debt | $1.1B | $1.2B | $1.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jul 29, 2026 | Jul 27, 2026 |
All 338 Fortrea Holdings Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.